The 17th MegaGen International Symposium in Rome, Italy, will be held from May 30 to June 1, 2024. Organized by MegaGen, a leading dental implant company, the event gathers dental experts worldwide to discuss the latest technologies in implantology. Lumoral will be spotlighted at the event for its contribution to enhancing oral health for patients undergoing or considering implant treatments.

With the theme "All Roads Lead to Rome - Revolutionary Advances; The Journey to Full Mouth Restorations with Immediate Implants", the MegaGen symposium serves as a platform for networking, knowledge exchange, and professional development.  

At the event, attendees can participate in lectures, workshops, and hands-on training sessions led by renowned speakers and key opinion leaders in the oral health field. Topics covered during the symposium will include digital dentistry, immediate implant placement, surgical techniques, prosthetic dentistry, and more.

– For our Lumoral team, the event offers an invaluable opportunity to stay up-to-date on the latest developments in the field of implantology. It also provides professionals in the implant industry with a great chance to introduce themselves with antibacterial Lumoral treatment and the benefits it offers to patients, says Tero Pasanen, Chief Commercial Officer of Koite Health Ltd.

Expanding Implant Market Spurs Demand for Lumoral Antibacterial Treatment

The global dental implants market is flourishing because of a growing prevalence of dental diseases and tooth loss, an aging population, and the rapid adoption of technological advancements and digital technologies, such as computer-aided design and 3D printing, in dental implant materials and design. 

Pasanen notes that with the implant industry expanding, the need for advanced oral hygiene methods, including Lumoral, is also growing. 

Finnish health technology company Koite Health Ltd. has been in a Lumoral distribution agreement with MegaGen Italia since May of last year. Pasanen notes that the event in Rome is a natural progression of the collaboration, helping to raise awareness of antibacterial light-activated Lumoral treatment among the participants.

Oral home care is very important for the health of dental implants. Because 95 percent of dental diseases are caused by bacteria in the plaque, regularly eliminating dental plaque improves dental hygiene as well as prevents and treats dental and gum disease. Proper oral hygiene combined with regular use of Lumoral could be decisive in preventing periodontitis and peri-implantitis.

Lumoral brings many benefits to implant patients: it helps sustain oral bacterial diversity while reducing plaque bacteria, it reduces gingivitis and plaque and tartar formation, and treats and prevents periodontitis and peri-implantitis efficiently.

– We believe that it is an excellent idea that dentists would offer a Lumoral device to all their implant patients to help prevent peri-implantitis and help keep the implants healthy, Mr. Federico Annoni from Megagen Italia said in an earlier interview.

If you want to improve your athletic performance, there are many things you can do. Contrary to popular belief, maintaining optimal oral health can significantly impact athletic performance, as confirmed by recent scientific studies.

Recent research has highlighted the close connection between gum inflammation (gingivitis/periodontitis) and athletic performance. According to leading experts, severity of inflammation directly correlates with decreased performance in activities such as weightlifting and fitness tests. 

Gingivitis, characterized by inflammation of the gums due to plaque buildup, and periodontitis, a more severe condition affecting both the gums and the supporting jawbone, are prevalent oral health issues. Left untreated, these conditions can lead to tooth loss and other serious complications. 

To address this critical issue, Finnish scientists have developed a revolutionary solution designed to combat plaque and inflammation effectively. Lumoral utilizes innovative light-activated technology, scientifically proven in numerous studies, to target and eliminate harmful oral bacteria, which is associated with 95 % of all oral diseases. 

Annimari is one of the fastest Finnish 100-meter hurdle runners ever. Since adding antibacterial light-activated treatment to her oral hygiene routine, Annimari has noticed a significant improvement in her gum health. 

Test your inflammation status! 

Attendees of the FIBO event, taking place at the Exhibition Centre Cologne, Germany, from April 11th to 14th, will have the exclusive opportunity to test their inflammation status at the Lumoral booth (Hall 5.2 Stand B 42). Through a quick and simple test, participants can determine whether inflammatory processes are occurring in their mouths, providing valuable insights into their oral health status. The test, worth € 60, is free of charge at the FIBO event.

Furthermore, attendees can learn more about the future of oral care. Lumoral offers targeted inflammation control, enabling athletes and individuals alike to maintain optimal oral health and enhance their performance. By incorporating Lumoral into their dental care routine, professionals, recreational and age group athletes can prevent tooth and gum disease, paving the way for improved athletic performance and overall well-being. 

- We are excited to unveil Lumoral's groundbreaking research at FIBO, highlighting the profound impact of oral health on athletic performance, said Sakari Nikinmaa, CEO at Koite Health Ltd.  

Don't miss the opportunity to discover the future of dental care and its implications for athletic performance at FIBO. Visit the Lumoral booth to learn more about this innovative solution and take the first step towards a healthier, more successful lifestyle. You can also attend the two lectures on this topic, one on Saturday at 10:00 and the other on Sunday at 16:40. The lectures will take place in the Nutrition & Diagnostics Area in Hall 4.2.

For more information about Lumoral, please visit www.zeroplaque.de OR www.lumoralpro.com.

Periodontitis and diabetes are two prevalent diseases with a strong bidirectional relationship between them. Poorly managed diabetes promotes the progression of periodontitis and complicates its treatment. Conversely, active periodontitis adversely affects diabetes management and treatment.

In honor of World Health Day, Tommi Pätilä, a heart and transplant surgeon at HUS New Children's Hospital, in Finland, and Timo Sorsa, a professor of oral and maxillofacial diseases at the University of Helsinki, reflect on the connection between these two prevalent diseases from the perspective of oral health.

Diabetes and gum inflammation are two significant global health issues that require immediate attention. About half of the world's population suffers from gum inflammation, while nearly half a billion people have diabetes.

In Finland alone, there are approximately 500,000 diabetics, with about 50,000 suffering from type 1 diabetes and around 400,000 from type 2 diabetes. Additionally, it is estimated that there are up to 100,000 undiagnosed type 2 diabetics in Finland.

Understanding the Close Connection

Periodontitis is a disease of the tooth-supporting tissues that progresses from gum inflammation and can ultimately lead to tooth loss. Symptoms of the disease include red, swollen, and bleeding gums, gum recession, formation of gum pockets, loosening of teeth, bad breath, and possible swallowing and chewing problems.

Periodontitis is associated with many risk factors, such as smoking, genetic factors, and systemic diseases like diabetes.

The symptoms of the disease can vary from mild to severe and often require evaluation and treatment by a dentist or dental hygienist. Early detection and treatment are crucial for managing periodontitis.

Diabetic patients have an increased risk of developing periodontitis, and conversely, periodontitis has a negative impact on diabetes treatment and management. High blood sugar levels increase inflammation in the mouth and hinder the healing of periodontitis. The combined effect of these two diseases is also reflected in systemic inflammatory markers and blood sugar levels.

Traditional diagnostic methods are not always sufficient to identify the risk of periodontitis and diabetes. Therefore, new biomarker-based rapid tests have been developed to help identify the risk of these diseases at an early stage.

Oral Health Status Revealed in Minutes

The aMMP-8 rapid test developed in Finland is based on measuring the concentration of active matrix metalloproteinase 8 (aMMP-8) in mouthwash. Studies have shown that elevated levels of aMMP-8 may indicate both periodontitis and diabetes.

The aMMP-8 rapid test can be performed at the dentist's office, and the results are obtained immediately. This allows for early intervention in the development of periodontitis and assessment of the risk of diabetes. Additionally, the test provides patients with important information about their oral health and the risk of diabetes, which encourages better self-care and adherence to healthy lifestyles.

"The test allows for the detection of signs of periodontitis even before symptoms occur, which provides an opportunity for early treatment and prevention of complications," says Professor Timo Sorsa of the University of Helsinki's Department of Oral and Maxillofacial Diseases.

The test has proven to be useful in screening patients with type I, type II, and gestational diabetes.

Oral Health: A Crucial Factor for Diabetics

Diabetic patients with periodontitis require special attention, reminds pediatric heart and transplant surgeon Tommi Pätilä. Pätilä is also one of the developers of the Lumoral innovation, which enhances mechanical oral hygiene.

"It is especially important for diabetics to invest in regular oral hygiene and dental visits. This not only improves patients' quality of life but also reduces the risk of long-term complications," says Pätilä.

According to Pätilä, adjunctive therapies can be combined with at-home oral hygiene management, such as low-dose doxycycline acting as an aMMP-8 inhibitor and light-activated mouthwashes with anti-inflammatory effects.

"Antibacterial Lumoral treatment effectively removes harmful plaque bacteria from tooth surfaces and gum lines. Home-administered Lumoral treatment has been shown to be significantly more effective and better tolerated than chlorhexidine-based mouthwashes commonly used today," Pätilä explains.

Pätilä emphasizes that antibacterial treatment complements mechanical tooth cleaning and does not replace the need for brushing and cleaning between teeth. Why is additional treatment needed to enhance mechanical oral cleaning?

"Research shows that brushing only removes 65% of plaque. Residual plaque remains in the mouth even after the most effective brushing. Lumoral helps remove this residual plaque. Regular Lumoral treatment ensures that tooth surfaces are thoroughly clean. Diabetics, in particular, benefit from this removal of residual plaque," says Pätilä.

According to studies, regular adjunctive antibacterial treatment alongside traditional non-surgical standard treatment reduces inflammation in gum tissues and improves oral hygiene and healing of deep pockets in chronic periodontitis compared to conventional treatment.

Antibacterial treatment has also been shown to prevent and improve inflammation of peri-implant tissues. The treatment is suitable for everyone, but light-activated antibacterial treatment is seen as most effective for patients who require enhanced oral hygiene.

***

World Health Day, launched by the World Health Organization (WHO), is celebrated globally on April 7th to increase awareness of health issues. This year, the timely theme "My health, my right" emphasizes the importance of health equity.

*** 

References:

Trujillo K, Räisänen IT, Sorsa T, Pätilä T. Repeated daily use of dual-light antibacterial photodynamic therapy in periodontal disease—a case report. Dent J (Basel). 2022;10(9):163. doi:10.3390/dj10090163

Pakarinen S, Saarela RKT, Välimaa H, et al. Home-applied dual-light photodynamic therapy in the treatment of stable chronic periodontitis (HOPE-CP)—three-month interim results. Dent J (Basel). 2022;10(11):206. doi:10.3390/dj10110206

Gholami L, Shahabi S, Jazaeri M, Hadilou M, Fekrazad R. Clinical applications of antimicrobial photodynamic therapy in dentistry. Front Microbiol. 2023;13:1020995. doi:10.3389/fmicb.2022.1020995

Lähteenmäki H, Pätilä T, Räisänen I, Kankuri E, Tervahartiala T, Sorsa T. Repeated Home-Applied Dual-Light Antibacterial Photodynamic Therapy Can Reduce Plaque Burden, Inflammation, and aMMP-8 in Peri-Implant Disease – A Pilot Study. Curr Issues Mol Biol 2022; 44: 1273–1283. doi: 10.3390/cimb44030085